Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss of $0.04/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss of $0.04/Share

Aurinia Reports Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights

March 15, 2018 4:02 PM EDT

AURORA Phase III Trial in lupus nephritis on track

Trials in FSGS and Dry Eye to begin in Q2 2018

Cash of $173.5 million as of December 31, 2017

VICTORIA, British Columbia--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX: AUP) (Aurinia or the Company) has released its financial results for the fourth quarter and year ended December 31, 2017. Amounts, unless specified otherwise, are expressed in U.S. dollars.

Aurinia gained remarkable momentum in 2017, as demonstrated by the achievement of all of our important... More